Results

Total Results: 634 records

Showing results for "rapid response".

481. Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
     January 01, 2018 - ACO registries can also be used for rapid cycle patient-oriented outcomes research, efforts that are

482. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
     June 01, 2010 - the public comment period, comparative effectiveness research reviews are revised by the authors in response … The table below includes the response by the authors of the review to each comment submitted for the … Source: www.effectivehealthcare.ahrq.gov Published Online June 1, 2010 Section Comment Response … The (admittedly informal) response I have gotten is that 80% of patients in the US are off-label, but … In trauma, uncontrolled bleeding leads to rapid death.

483. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - ES-2 reduced RLS symptoms, increased the percentage of patients with a clinically important response … and etiology of disease, age, obesity, and other characteristics that appear to have an effect on response … rotigotine) reduced RLS symptoms, increased the percentage of patients with a clinically important response … evidence demonstrated that pregabalin increased the percentage of patients with a clinically important response … stakeholders to clarify or supplement the call summaries or to suggest additional research questions in response

484. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
     January 01, 2013 - may seem to be a natural choice when there is a dramatic s hift from one treatment to another (e.g., rapid … Evaluation of response time data involving transient states: an illustration using heart-transplant data

485. Breast-Abnormalities-Tests-Update Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
     July 01, 2010 - Background and Objectives In response to Section 1013 of the Medicare Modernization Act, the Agency … asymptomatic women; breast cancer staging; evaluation for a possible recurrence of breast cancer; monitoring response

486. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
     March 01, 2010 - It is a collaborative network of research centers that support the rapid development of new scientific … hydralazine/isosorbide dinitrate (H-ISDN) combination* VARIABLE GROUP Variable Categorical response

487. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
     January 01, 2009 - period: attrition rate before randomization and reasons (e.g., nonadherence, adverse drug events, no response … If high levels of nonadherence, adverse effects, or lack of response are found, then this reduces applicability

488. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - • There is limited indirect comparison evidence that the effect on clinically important response may … Most studies used flexible up-titration based on symptom response and adverse effects, with doses ranging … Compared with placebo, the percentage of patients with a favorable treatment response was greater with … studies as the basis for increasing drug doses or altering administration timing if symptom response … Moreover, clinicians and patients should be aware of such a large placebo response.

489. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
     April 01, 2010 - It is a collaborative network of research centers that support the rapid development of new scientific … plan for depression should be documented If a patient with cancer is treated for depression, then response

490. Methods Guide for Medical Test Reviews Chapter 12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
     July 01, 2012 - Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy

491. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - Other factors that may be considered in assessing strength of evidence include dose-response relationship

492. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - Ticagrelor is a reversible P2Y12 receptor antagonist that, when compared with clopidogrel, provides a more rapid … Initial pharmacokinetic/pharmacodynamic studies have suggested a reduction in the antiplatelet response … Based on comments received in response to this posting, the following change was made to the KQs: … Additionally, when appropriate, the studies will be evaluated for dose-response association, the presence

493. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - It is a collaborative network of research centers that support the rapid development of new scientific … early events, especially treatment discontinuations, because of problems with tolerability or poor response … Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from

494. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
     August 18, 2011 - helping patients to better adhere to recommended treatment. 4-6 Over the past half century, rapid … and alternatives to the prescribed medication; and lack of access to a provider who will monitor the response … It also considers other optional domains that may be relevant for some scenarios, such as a dose-response

495. Glaucoma-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
     January 01, 2013 - Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program

496. Epilepsy-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
     August 01, 2012 - subject matter experts referred to a publication outlining perceived shortcomings of the report and a response … The response from the epilepsy organizations highlighted that the report failed to recognize the different … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response … Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response

497. Epilepsy-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
     August 01, 2012 - subject matter experts referred to a publication outlining perceived shortcomings of the report and a response … The response from the epilepsy organizations highlighted that the report failed to recognize the different … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response … Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response

498. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - If C1INH is deficient, an acute inflammatory response occurs that leads to swelling, which is the … If C1INH is deficient, C1 proteases set off the complement pathway, causing an acute inflammatory response … Part of the inflammatory response is the release of uncontrolled levels of bradykinin (BK), a potent … The combination of rapid relief of symptoms and self-administration is expected to improve health outcomes … the retina using tests for refraction, color vision, visual field, visual acuity, and pupil-reflex response

499. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
     August 01, 2014 - from draft CER for procalcitonin as a diagnostic indicator for infection and as an indicator of response … from draft CER for procalcitonin as a diagnostic indicator for infection and as an indicator of response … The response rate was 100 percent (n=9); 8 (of 10) research needs received votes. … The response rate was 100 percent (n=9); all questions received votes. … Host cytokine response affects PCT levels, so PCT cut-offs may differ in these populations.

500. Labor-Nitrous-Oxide Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
     August 01, 2012 - Nitrous oxide has a rapid onset and end of action.